690 related articles for article (PubMed ID: 11751407)
1. Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease.
Taback B; Chan AD; Kuo CT; Bostick PJ; Wang HJ; Giuliano AE; Hoon DS
Cancer Res; 2001 Dec; 61(24):8845-50. PubMed ID: 11751407
[TBL] [Abstract][Full Text] [Related]
2. Detection of circulating breast cancer cells in peripheral blood by a two-marker reverse transcriptase-polymerase chain reaction assay.
Fabisiewicz A; Kulik J; Kober P; Brewczyńska E; Pieńkowski T; Siedlecki JA
Acta Biochim Pol; 2004; 51(3):747-55. PubMed ID: 15448736
[TBL] [Abstract][Full Text] [Related]
3. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
[TBL] [Abstract][Full Text] [Related]
4. Detection of MAGE-A3 in breast cancer patients' sentinel lymph nodes.
Wascher RA; Bostick PJ; Huynh KT; Turner R; Qi K; Giuliano AE; Hoon DS
Br J Cancer; 2001 Nov; 85(9):1340-6. PubMed ID: 11720472
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneous expression of MAGE-A genes in occult disseminated tumor cells: a novel multimarker reverse transcription-polymerase chain reaction for diagnosis of micrometastatic disease.
Kufer P; Zippelius A; Lutterbüse R; Mecklenburg I; Enzmann T; Montag A; Weckermann D; Passlick B; Prang N; Reichardt P; Dugas M; Köllermann MW; Pantel K; Riethmüller G
Cancer Res; 2002 Jan; 62(1):251-61. PubMed ID: 11782385
[TBL] [Abstract][Full Text] [Related]
6. The melanoma antigen gene as a surveillance marker for the detection of circulating tumor cells in patients with breast carcinoma.
Kwon S; Kang SH; Ro J; Jeon CH; Park JW; Lee ES
Cancer; 2005 Jul; 104(2):251-6. PubMed ID: 15937912
[TBL] [Abstract][Full Text] [Related]
7. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
[TBL] [Abstract][Full Text] [Related]
8. [Detection of alpha-fetoproteins mRNA and melanoma antigen-1 mRNA in peripheral blood of patients with hepatocellular carcinoma and its clinical significance].
Yang SZ; Dong JH; Zhu J; Li K; Zhang Y
Zhonghua Wai Ke Za Zhi; 2004 Sep; 42(17):1060-3. PubMed ID: 15498320
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous detection of multiple mRNA markers CK19, CEA, c-Met, Her2/neu and hMAM with membrane array, an innovative technique with a great potential for breast cancer diagnosis.
Chen CC; Hou MF; Wang JY; Chang TW; Lai DY; Chen YF; Hung SY; Lin SR
Cancer Lett; 2006 Aug; 240(2):279-88. PubMed ID: 16289546
[TBL] [Abstract][Full Text] [Related]
10. Detection of melanoma cells in the blood of melanoma patients by melanoma-inhibitory activity (MIA) reverse transcription-PCR.
Mühlbauer M; Langenbach N; Stolz W; Hein R; Landthaler M; Buettner R; Bosserhoff AK
Clin Cancer Res; 1999 May; 5(5):1099-105. PubMed ID: 10353744
[TBL] [Abstract][Full Text] [Related]
11. Presence of erbB2 mRNA in the plasma of breast cancer patients is associated with circulating tumor cells and negative estrogen and progesterone receptor status.
Xu Y; Yao L; Li H; Ouyang T; Li J; Wang T; Fan Z; Lin B; Lu Y; Larsson O; Xie Y
Breast Cancer Res Treat; 2006 May; 97(1):49-55. PubMed ID: 16319978
[TBL] [Abstract][Full Text] [Related]
12. Assessment of messenger RNA of beta 1-->4-N-acetylgalactosaminyl-transferase as a molecular marker for metastatic melanoma.
Kuo CT; Bostick PJ; Irie RF; Morton DL; Conrad AJ; Hoon DS
Clin Cancer Res; 1998 Feb; 4(2):411-8. PubMed ID: 9516930
[TBL] [Abstract][Full Text] [Related]
13. Detection of circulating breast cancer cells with multiple-marker RT-PCR assay.
Hu XC; Chow LW
Anticancer Res; 2001; 21(1A):421-4. PubMed ID: 11299772
[TBL] [Abstract][Full Text] [Related]
14. [Molecular staging of testicular cancer using polymerase chain reaction of the testicular cancer-specific genes].
Nonomura N; Imazu T; Harada Y; Nozawa M; Ono Y; Fukui T; Nishimura K; Okuyama A
Hinyokika Kiyo; 1999 Aug; 45(8):593-7. PubMed ID: 10500969
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of MUC1 and c-Met RT-PCR detection of circulating tumor cells in patients with gastric carcinoma.
Uen YH; Lin SR; Wu CH; Hsieh JS; Lu CY; Yu FJ; Huang TJ; Wang JY
Clin Chim Acta; 2006 May; 367(1-2):55-61. PubMed ID: 16403482
[TBL] [Abstract][Full Text] [Related]
16. Detection of circulating breast cancer cells by reverse transcriptase polymerase chain reaction (RT-PCR).
Hu XC; Chow LW
Eur J Surg Oncol; 2000 Sep; 26(6):530-5. PubMed ID: 11034801
[TBL] [Abstract][Full Text] [Related]
17. Human mammaglobin mRNA is a reliable molecular marker for detecting occult breast cancer cells in peripheral blood.
Roncella S; Ferro P; Bacigalupo B; Pronzato P; Tognoni A; Falco E; Gianquinto D; Ansaldo V; Dessanti P; Fais F; Rosai J; Fedeli F
J Exp Clin Cancer Res; 2005 Jun; 24(2):265-71. PubMed ID: 16110760
[TBL] [Abstract][Full Text] [Related]
18. Detection of circulating tumor cells in early-stage breast cancer metastasis to axillary lymph nodes.
Nakagawa T; Martinez SR; Goto Y; Koyanagi K; Kitago M; Shingai T; Elashoff DA; Ye X; Singer FR; Giuliano AE; Hoon DS
Clin Cancer Res; 2007 Jul; 13(14):4105-10. PubMed ID: 17634536
[TBL] [Abstract][Full Text] [Related]
19. [Detection of tumor cells in peripheral blood of patients with gastric cancer using mRNA of MAGE genes as markers].
Wang WX; Li YB; Xie XL; Shu XL; Ouyang XH
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Nov; 12(6):611-4. PubMed ID: 19921576
[TBL] [Abstract][Full Text] [Related]
20. Detection of occult HER2 mRNA-positive tumor cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic relevance.
Apostolaki S; Perraki M; Kallergi G; Kafousi M; Papadopoulos S; Kotsakis A; Pallis A; Xenidis N; Kalmanti L; Kalbakis K; Agelaki S; Kalykaki A; Stournaras C; Stathopoulos E; Georgoulias V; Mavroudis D
Breast Cancer Res Treat; 2009 Oct; 117(3):525-34. PubMed ID: 19016323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
